Paul-Ehrlich-Institut

Al­bu­mins

Albumins belong to the group of plasma proteins. Albumins serve as transport proteins in the blood and are responsible for the colloid osmotic pressure of blood plasma. They are, for instance, used to stabilize the blood circulation volume in the event of strong bleeding.

Name Mar­ket­ing Au­tho­ri­sa­tion Hold­er Li­cense Num­ber Li­cense Date Further Information

Al­biomin 5%

Biotest Phar­ma GmbH

PEI.H.03575.01.1 22.06.2007

Al­biomin 20%

Biotest Phar­ma GmbH

PEI.H.03574.01.1 22.06.2007

Al­bume­on

CSL Behring GmbH

PEI.H.11655.01.1 24.05.2013

Al­bunorm 4%

Oc­taphar­ma GmbH

PEI.H.04333.05.1 20.07.2015

Al­bunorm 5%

Oc­taphar­ma GmbH

PEI.H.04333.01.1 26.03.2009

Al­bunorm 20%

Oc­taphar­ma GmbH

PEI.H.04333.02.1 26.03.2009

Al­bunorm 20%

Ori­farm GmbH

PEI.H.11964.01.1 22.05.2018

Al­bunorm 25%

Oc­taphar­ma GmbH

PEI.H.04333.06.1 20.07.2015

Al­bu­rex 5

CSL Behring GmbH

PEI.H.11429.01.1 25.01.2010

Al­bu­rex 20

CSL Behring GmbH

PEI.H.11429.02.1 25.01.2010

Al­butein 50 g/l

Gri­fols Deutsch­land GmbH

10576a/97 08.02.2000

Al­butein 200 g/l

Gri­fols Deutsch­land GmbH

10577a/97 08.02.2000

Cre­alb 40g/l

San­quin Plas­ma Prod­ucts B.V., Nieder­lande

PEI.H.12044.01.1 24.09.2020

Cre­alb 200g/l

San­quin Plas­ma Prod­ucts B.V., Nieder­lande

PEI.H.12044.02.1 24.09.2020

HU­MAN AL­BU­MIN 50g/l Bax­al­ta

Shire Deutsch­land GmbH

PEI.H.03271.01.1 01.04.2006

HU­MAN AL­BU­MIN 200g/l Bax­al­ta

Shire Deutsch­land GmbH

PEI.H.03272.01.1 01.04.2006

HU­MAN AL­BU­MIN 250g/l Bax­al­ta

Shire Deutsch­land GmbH

PEI.H.03273.02.1 02.12.2016

Hu­man-Al­bu­min 20% Behring, salzarm

CSL Behring GmbH

10530a/96 27.01.1997

Hu­manal­bin

CSL Behring GmbH

10531a/96 09.02.1999

Hu­manal­bu­min 200 g/l Kedri­on

KEDRI­ON S.p.A.

PEI.H.02994.01.1 12.12.2003

Plas­bu­min 20

Gri­fols Deutsch­land GmbH

4962.01.00 06.08.1984

Plas­bu­min 25

Gri­fols Deutsch­land GmbH

10537a/96 26.05.1999

Hints

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 479 in BAnz AT 01.04.2021 B11.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Updated: 01.04.2021